Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

9480	Companies
185558	Keywords
117947	Articles
99388	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 08/01/2025 at 13:05, 4 months 4 days ago

Résultats financiers et mises à jour de l'activité de Moderna pour le deuxième trimestre 2025

Gestion Des Coûts Approbations De La FDA Chiffre D'affaires Du Deuxième Trimestre 2025 Résultats Financiers De Moderna Ventes De Vaccins
BRIEF

published on 08/01/2025 at 13:05, 4 months 4 days ago

Moderna's Q2 2025 Financial Results and Business Updates

Cost Management FDA Approvals Q2 2025 Revenue Moderna Financial Results Vaccine Sales
PRESS RELEASE

published on 08/01/2025 at 13:00, 4 months 4 days ago

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
Moderna reports Q2 revenue of $0.1B, net loss of $(0.8)B, updates 2025 revenue to $1.5-$2.2B due to shipment timing, improves operating expenses by $400M, reiterates $6B year-end cash balance. FDA approvals for flu vaccine

Revenue Moderna Q2 2025 FDA Approvals
BRIEF

published on 08/01/2025 at 12:05, 4 months 4 days ago

UK Court Confirms Validity of Moderna's EP'949 Patent

Patent MRNA Technology Moderna Pfizer/BioNTech UK Court
BRIEF

published on 08/01/2025 at 12:05, 4 months 4 days ago

Un tribunal britannique confirme la validité du brevet EP'949 de Moderna

Brevet Moderne Pfizer/BioNTech Technologie De L'ARNm Tribunal Du Royaume-Uni
PRESS RELEASE

published on 08/01/2025 at 12:00, 4 months 4 days ago

UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech
Moderna's EP'949 patent validity upheld by UK Court of Appeal in Pfizer/BioNTech case. Recent legal developments in Europe further strengthen Moderna's intellectual property portfolio

MRNA Technology Moderna Pfizer/BioNTech EP'949 Patent UK Court Of Appeal
BRIEF

published on 07/30/2025 at 22:10, 4 months 5 days ago

Moderna Gains European Approval for New COVID-19 Vaccine

COVID-19 Vaccine European Commission Moderna SARS-CoV-2 SPIKEVAX®
BRIEF

published on 07/30/2025 at 22:10, 4 months 5 days ago

Moderna obtient l'approbation européenne pour son nouveau vaccin contre la COVID-19

SRAS-CoV-2 Moderne Vaccin Contre Le Covid-19 Commission Européenne SPIKEVAX®
PRESS RELEASE

published on 07/30/2025 at 22:05, 4 months 5 days ago

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Moderna receives marketing authorization from the European Commission for updated COVID-19 vaccine Spikevax® targeting SARS-CoV-2 variant LP.8.1

COVID-19 Vaccine European Commission Moderna Spikevax LP.8.1
BRIEF

published on 07/28/2025 at 13:05, 4 months 8 days ago

Moderna présentera ses données thérapeutiques à base d'ARNm au congrès de l'ESMO 2025

Cancer De La Vessie Moderne Mélanome Thérapies À Base D'ARNm Congrès ESMO 2025

Accesswire

Published on 12/05/2025 at 21:45, 15 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 30 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 40 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 35 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 3 hours 2 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 3 hours 34 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 3 hours 45 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 4 hours 9 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 4 hours 14 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 4 hours 42 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 42 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 50 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 50 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 2 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE